v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Gross sales $ 7,782,208 $ 7,224,957
Sales discounts & allowances (414,425) (379,287)
Revenue, net 7,367,783 6,845,670
Cost of goods sold 6,142,848 5,465,314
Depreciation and amortization 386,044 480,554
Total cost of goods sold 6,528,892 5,945,868
Gross profit 838,891 899,802
Total sales, general & administrative expenses 2,900,040 3,816,920
Loss from operations (2,061,149) (2,917,118)
Other income (expense):    
Loss on foreign exchange rates (1,143) (11,047)
Interest expense (1,450,126) (1,259,423)
Total other expense (1,451,269) (1,270,470)
Loss before income taxes (3,512,418) (4,187,588)
Income tax expense
Net loss $ (3,512,418) $ (4,187,588)
Loss per share from net loss    
Basic (in Dollars per share) $ (0.16) $ (0.2)
Diluted (in Dollars per share) [1] $ (0.16) $ (0.2)
Weighted average shares outstanding    
Basic (in Shares) 21,428,650 21,379,347
Diluted (in Shares) 21,428,650 21,379,347
[1] In periods where the Company has incurred a net loss, diluted earnings per share is based on the number of common shares issued and outstanding as including the effects of warrants would be anti-dilutive.